Advertisement
UK markets close in 6 hours 59 minutes

  • FTSE 100

    8,424.05
    +42.70 (+0.51%)
     

  • FTSE 250

    20,604.10
    +72.80 (+0.35%)
     

  • AIM

    785.66
    +1.96 (+0.25%)
     

  • GBP/EUR

    1.1623
    +0.0012 (+0.10%)
     

  • GBP/USD

    1.2534
    +0.0010 (+0.08%)
     

  • Bitcoin GBP

    50,217.36
    +1,276.86 (+2.61%)
     

  • CMC Crypto 200

    1,303.93
    -54.08 (-3.98%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • DOW

    39,387.76
    +331.36 (+0.85%)
     

  • CRUDE OIL

    79.54
    +0.28 (+0.35%)
     

  • GOLD FUTURES

    2,375.40
    +35.10 (+1.50%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,801.92
    +115.32 (+0.62%)
     

  • CAC 40

    8,232.76
    +45.11 (+0.55%)
     
PROPERTY:

Homes with investment potential

These residential properties could bring in a good ROI

Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·25-min read
Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript

At this time, I would like to welcome everyone to the Arbutus Biopharma 2022 second quarter financial results and corporate update. Good morning, everyone, and thank you for joining our second quarter 2022 financial results and corporate update call. Joining me today from the Arbutus executive team are Bill Collier, president and chief executive officer; David Hastings, chief financial officer; Dr. Gaston Picchio, chief development officer; and Dr.

Continue reading